![Juan I Enghelmayer 2022🇦🇷 Profile](https://pbs.twimg.com/profile_images/1573879565650468864/fczN1WZb_x96.jpg)
Juan I Enghelmayer 2022🇦🇷
@Juani1000
Followers
1K
Following
3K
Statuses
2K
Pulmonologist. Hospital de Clinicas.. Buenos Aires University. Argentina. #Pulmonary Fibrosis. #ILD.
Buenos Aires, Argentina
Joined June 2009
On November 23rd, we will be speaking at the Global Southeast Asian Webinar alongside @MariaOtaola and esteemed international colleagues and friends. Thank you, Drs. @Katerina Antoniou, @Gina_amanda and @naziachaudhuri, for the invitation! Registration link:
0
0
5
@leticiakawano Yes, I’ve noticed that the new algorithm doesn’t just reduce the views on my posts—it also brings me less diverse content from others. I keep seeing the same things repeatedly, and it’s limiting my experience on the platform.
0
1
2
RT @tkulkarn1: Our @AnnalsATS paper exploring factors associated with persistence of antifibrotic therapies among patients with IPF enrolle…
0
9
0
Enjoying my last breakfast with a view of the Acropolis before heading back to Argentina. After an incredible #ICLAF2024. I explored the birthplace of Western culture and shared meaningful moments with friends and colleagues from all over the world. So grateful to everyone. 🇦🇷🇬🇷
0
1
21
Great talk by @KerriBerriKerri on the crucial and often overlooked topic of sexual activity in pulmonary fibrosis! #ICLAF2024
Groundbreaking work on sexual function in patients with ILD by @KerriBerriKerri and @NaamaAvitzur presented AT #ICLAF2024! Critically important issue we need to think about and address with our patients 🙌🙌🙌
0
1
10
@KaminskiMed delivering the Andy Tager Lecture at #ICLAF2024, presenting the best explanation I’ve ever heard on the genesis of pulmonary fibrosis. “The Role of Aberrant Basaloid Cells in Pulmonary Fibrosis”. Truly groundbreaking insights!
1
3
14
RT @IPFthurles: Great to hear from the patients at #ICLAF2024 with @EU_IPFF's @John_solheim and Steve Jones @ActionPFsteve speaking amid…
0
3
0
RT @PilarRiveraOrt1: Dear #ILD community, On behalf of the @RespirEffect IPF/ILD working group, it is my pleasure to share our most recent…
0
26
0
Great lessons from Athol wells in #ICLAF2024: “We need an integrated classification combining diagnosis and disease behavior. Flexibility in treatment is essential, but current tools are insufficient. Advanced therapies like #AI and imaging hold promise”
0
2
12
Nice opening of #ICLAF2024 with ‘The Patient Journey,’ discussing how to improve clinical trials to make them more inclusive and diverse for our patients
0
1
9